

David and Goliath: How Can First-Time Launchers Avoid Failure and Beat Big Pharma Launches with Rohit Sood, Executive Vice President at EVERSANA
Oct 12, 2022
Rohit Sood, Executive Vice President at EVERSANA discusses the increase in first-time launchers, the reasons behind their failure rates, and lessons to be learned from big pharma launches. They also touch on adapting to circumstances and strategy, ownership incentives for first-timers, emerging markets, and the importance of lifelong learning in pharma marketing.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Introduction
00:00 • 2min
Changes in Biotech and Pharma Launches after COVID-19
01:31 • 8min
Challenges and High Stakes of First-Time Pharma Launches
09:30 • 19min
The Advantage of Ownership Incentives for First-Time Pharma Launchers and the Potential of Neuroscientific Treatments
28:26 • 3min
Emerging Markets, Buzzwords, and Book Recommendations
31:08 • 2min
Eclectic Taste in Music and the Importance of Lifelong Learning in Pharma Marketing
33:10 • 3min